Latest stories, analysis, and insights from the world of health.
Early data from Utah's five-month pilot program with AI startup Doctronic reveals the system renewed prescriptions 72% of the time without physician escalation, though independent review of the pilot's safety claims is still pending. The experiment tests whether AI can legally assist with prescription renewals while operating under the state's AI innovation regulatory sandbox.
Australia has confirmed its first diphtheria death since 2018 as the country experiences its worst outbreak of the vaccine-preventable disease in decades, with 245 cases reported in 2026 primarily affecting remote Indigenous communities.
Kyle Diamantas, the acting FDA commissioner, has earned significant trust and exceeded expectations in his role leading the regulatory agency during a critical period.
Australia has recorded its first diphtheria death since 2018 as the country experiences its worst outbreak of the vaccine-preventable disease in decades, with 245 cases primarily affecting remote Indigenous communities.
Eli Lilly announced that its gene-editing therapy VERVE-102 reduced cholesterol levels by 62% in Phase 1 clinical trial participants, with no treatment-related serious adverse events reported. The therapy, acquired through a $1 billion buyout of Verve Therapeutics, represents a potential one-time treatment to prevent heart disease.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths reported so far.
Eli Lilly has released Phase 1 trial data for VERV-102, a gene editing therapeutic designed to reduce cholesterol levels by targeting specific genetic pathways. The preliminary results represent a significant step forward in developing gene-based treatments for cardiovascular disease.
A new study reveals a dramatic rise in fake references in biomedical research, with fabricated citations increasing 12-fold since 2023, reaching a rate of one in 277 papers by early 2026, raising serious concerns about AI-generated misinformation in scientific literature.
Eli Lilly's experimental gene-editing therapy demonstrates early efficacy in Phase 1 trials for cholesterol management, marking a significant advancement in genetic treatment approaches.
Eli Lilly announced that its gene-editing therapy VERV-102 reduced LDL cholesterol by 62% in Phase 1 clinical trial participants, with no serious adverse events reported. The therapy, acquired in a $1 billion buyout of Verve Therapeutics, could offer a one-time treatment option for patients struggling with conventional cholesterol-lowering medications.
Experts warn that the perimenopause awareness movement is fueling misinformation, portraying women as slaves to their hormones, and driving a booming industry selling unproven supplements and treatments, while potentially causing women to overlook more serious health conditions.
The WHO has elevated the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 deaths reported so far from the rare Bundibugyo species.
An Ebola outbreak in the Democratic Republic of Congo has infected over 867 suspected cases and killed 204 people, with cases now spreading to neighboring Uganda. Health workers face major obstacles including community distrust, armed conflict, and a rare virus strain in remote mining regions.
A devastating measles outbreak in Bangladesh has killed over 500 children and sickened more than 60,000 since March 2026, largely due to vaccination campaign delays under the interim government and widespread childhood malnutrition.
RaDonda Vaught, convicted of negligent homicide after a fatal medication error at Vanderbilt Medical Center, has become a sought-after speaker sharing her cautionary tale to improve hospital safety systems in an era of automation and artificial intelligence.
Attacks on Ebola health facilities in eastern Democratic Republic of Congo are intensifying as tensions grow over burial protocols and cultural traditions clash with medical response efforts. The outbreak has claimed nearly 180 lives with close to 800 cases recorded, while mistrust and misinformation drive violence against treatment centres.
Two experts argue that the surge in perimenopause awareness is medicinalizing a natural life transition, blaming women's symptoms on hormones rather than aging or stress, while fueling a profitable industry of unproven supplements and treatments.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths reported. Scientists are developing new vaccines that could enter clinical trials within months.
Social media influencers and supplement companies are spreading misleading health claims about perimenopause treatments, prompting health experts to address dangerous misinformation about hormones and wellness products.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths from the rare Bundibugyo species.